It’s a mixed bag when it comes to opinions on penny stocks. These tickers trading for less than $5 per share divide Wall …
After passing one speed bump, is the market heading towards more bumps in the road? Following the September sell-off, there has been a …
Who’s next? After Gilead snapped up Immunomedics for $21 billion in September, gaining access to Trodelvy, an antibody conjugate that could be used …
Election day is just around the corner, and Wall Street is placing its bet on a Democratic sweep. Following the Presidential debate on …
Out on Wall Street, one group of stocks divides investors into either fans or critics. Penny stocks, or tickers that trade for less …
It can happen in a New York minute. We are talking about the massive gains certain healthcare stocks are able to notch in …
Since 2019, the healthcare sector has been bracing for the wild ride that would be the election year. However, according to some Street …
When it comes to the market’s wild swings, is the glass half empty or half full? Oppenheimer’s chief investment strategist John Stoltzfus is …
Bull or bear market, no investment is a sure thing. Especially in the current financial environment, which remains riddled with uncertainty, finding compelling …
For those that thought the extreme market volatility was behind us, think again. This month, another burst of volatility was brought on by …
